266 related articles for article (PubMed ID: 10833331)
21. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
22. Influence of 699C-->T and 1080C-->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels.
Aras O; Hanson NQ; Yang F; Tsai MY
Clin Genet; 2000 Dec; 58(6):455-9. PubMed ID: 11149614
[TBL] [Abstract][Full Text] [Related]
23. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms.
Fillon-Emery N; Chango A; Mircher C; Barbé F; Bléhaut H; Herbeth B; Rosenblatt DS; Réthoré MO; Lambert D; Nicolas JP
Am J Clin Nutr; 2004 Dec; 80(6):1551-7. PubMed ID: 15585767
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
Liu CS; Chiang HC; Chen HW
Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
[TBL] [Abstract][Full Text] [Related]
27. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
Malinow MR; Nieto FJ; Kruger WD; Duell PB; Hess DL; Gluckman RA; Block PC; Holzgang CR; Anderson PH; Seltzer D; Upson B; Lin QR
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1157-62. PubMed ID: 9194768
[TBL] [Abstract][Full Text] [Related]
28. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine, B-vitamins and CVD.
McNulty H; Pentieva K; Hoey L; Ward M
Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
[TBL] [Abstract][Full Text] [Related]
30. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
Gos M; Szpecht-Potocka A
J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
[TBL] [Abstract][Full Text] [Related]
31. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
[TBL] [Abstract][Full Text] [Related]
32. [Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
Luo D; Yan S; Cheng X; Song Y
Wei Sheng Yan Jiu; 2009 Jan; 38(1):39-42. PubMed ID: 19267073
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility to spina bifida; an association study of five candidate genes.
Morrison K; Papapetrou C; Hol FA; Mariman EC; Lynch SA; Burn J; Edwards YH
Ann Hum Genet; 1998 Sep; 62(Pt 5):379-96. PubMed ID: 10088035
[TBL] [Abstract][Full Text] [Related]
34. Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5'-phosphate concentration.
Tsai MY; Yang F; Bignell M; Aras O; Hanson NQ
Mol Genet Metab; 1999 Aug; 67(4):352-6. PubMed ID: 10444346
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women.
Silaste ML; Rantala M; Sämpi M; Alfthan G; Aro A; Kesäniemi YA
J Nutr; 2001 Oct; 131(10):2643-7. PubMed ID: 11584084
[TBL] [Abstract][Full Text] [Related]
36. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.
Tsai MY; Bignell M; Yang F; Welge BG; Graham KJ; Hanson NQ
Atherosclerosis; 2000 Mar; 149(1):131-7. PubMed ID: 10704624
[TBL] [Abstract][Full Text] [Related]
37. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults.
Kluijtmans LA; Young IS; Boreham CA; Murray L; McMaster D; McNulty H; Strain JJ; McPartlin J; Scott JM; Whitehead AS
Blood; 2003 Apr; 101(7):2483-8. PubMed ID: 12642343
[TBL] [Abstract][Full Text] [Related]
38. [CBS gene variations and serum homocysteine level associated with congenital heart defects].
Zhu W; Song X; Li M; Dao J
Wei Sheng Yan Jiu; 2008 Jul; 37(4):463-7. PubMed ID: 18839533
[TBL] [Abstract][Full Text] [Related]
39. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Tsai MY; Welge BG; Hanson NQ; Bignell MK; Vessey J; Schwichtenberg K; Yang F; Bullemer FE; Rasmussen R; Graham KJ
Atherosclerosis; 1999 Mar; 143(1):163-70. PubMed ID: 10208491
[TBL] [Abstract][Full Text] [Related]
40. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects.
Whitehead AS; Gallagher P; Mills JL; Kirke PN; Burke H; Molloy AM; Weir DG; Shields DC; Scott JM
QJM; 1995 Nov; 88(11):763-6. PubMed ID: 8542260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
